4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Firm
Client
Income
$35,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 486 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.